Zensar Technologies Limited (BOM:504067)
India · Delayed Price · Currency is INR 789.80
+5.25 (0.67%)
At close: Aug 7, 2025
Kronos Bio Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2017 - 2021 |
Operating Revenue | 53,775 | 52,806 | 49,019 | 48,482 | 42,438 | 37,814 | Upgrade |
| 53,775 | 52,806 | 49,019 | 48,482 | 42,438 | 37,814 | Upgrade | |
Revenue Growth (YoY) | 8.36% | 7.73% | 1.11% | 14.24% | 12.23% | -9.57% | Upgrade |
Cost of Revenue | 42,556 | 41,690 | 37,810 | 40,268 | 33,475 | 28,548 | Upgrade |
Gross Profit | 11,219 | 11,116 | 11,209 | 8,214 | 8,963 | 9,266 | Upgrade |
Selling, General & Admin | 297 | 297 | 284 | 240 | 235 | 288 | Upgrade |
Other Operating Expenses | 2,198 | 2,239 | 2,081 | 2,439 | 1,613 | 1,450 | Upgrade |
Operating Expenses | 3,752 | 3,809 | 3,749 | 4,519 | 3,770 | 4,084 | Upgrade |
Operating Income | 7,467 | 7,307 | 7,460 | 3,695 | 5,193 | 5,182 | Upgrade |
Interest Expense | -149 | -155 | -191 | -258 | -334 | -424 | Upgrade |
Interest & Investment Income | 1,067 | 1,067 | 903 | 406 | 234 | 139 | Upgrade |
Currency Exchange Gain (Loss) | -360 | -360 | 5 | 386 | 469 | -112 | Upgrade |
Other Non Operating Income (Expenses) | 268 | 125 | 144 | -34 | -2 | -128 | Upgrade |
EBT Excluding Unusual Items | 8,293 | 7,984 | 8,321 | 4,195 | 5,560 | 4,657 | Upgrade |
Gain (Loss) on Sale of Investments | 582 | 582 | 441 | 225 | 182 | 186 | Upgrade |
Gain (Loss) on Sale of Assets | 11 | 11 | -4 | 21 | -1 | -3 | Upgrade |
Asset Writedown | - | - | - | - | - | -20 | Upgrade |
Other Unusual Items | - | - | - | - | - | -491 | Upgrade |
Pretax Income | 8,886 | 8,577 | 8,758 | 4,441 | 5,741 | 4,329 | Upgrade |
Income Tax Expense | 2,147 | 2,079 | 2,108 | 1,165 | 1,524 | 1,259 | Upgrade |
Earnings From Continuing Operations | 6,739 | 6,498 | 6,650 | 3,276 | 4,217 | 3,070 | Upgrade |
Minority Interest in Earnings | - | - | - | - | -54 | -70 | Upgrade |
Net Income | 6,739 | 6,498 | 6,650 | 3,276 | 4,163 | 3,000 | Upgrade |
Net Income to Common | 6,739 | 6,498 | 6,650 | 3,276 | 4,163 | 3,000 | Upgrade |
Net Income Growth | 1.08% | -2.29% | 102.99% | -21.31% | 38.77% | 13.89% | Upgrade |
Shares Outstanding (Basic) | 227 | 227 | 227 | 226 | 226 | 225 | Upgrade |
Shares Outstanding (Diluted) | 229 | 229 | 228 | 228 | 228 | 228 | Upgrade |
Shares Change (YoY) | 0.22% | 0.09% | 0.35% | -0.16% | 0.12% | -0.34% | Upgrade |
EPS (Basic) | 29.70 | 28.65 | 29.36 | 14.47 | 18.43 | 13.31 | Upgrade |
EPS (Diluted) | 29.44 | 28.43 | 29.13 | 14.40 | 18.27 | 13.18 | Upgrade |
EPS Growth | 0.83% | -2.40% | 102.29% | -21.18% | 38.62% | 14.31% | Upgrade |
Free Cash Flow | - | 5,281 | 6,257 | 6,775 | 2,789 | 8,185 | Upgrade |
Free Cash Flow Per Share | - | 23.11 | 27.41 | 29.78 | 12.24 | 35.96 | Upgrade |
Dividend Per Share | - | 13.000 | 9.000 | 5.000 | 5.000 | 3.600 | Upgrade |
Dividend Growth | - | 44.44% | 80.00% | - | 38.89% | 28.57% | Upgrade |
Gross Margin | 20.86% | 21.05% | 22.87% | 16.94% | 21.12% | 24.50% | Upgrade |
Operating Margin | 13.89% | 13.84% | 15.22% | 7.62% | 12.24% | 13.70% | Upgrade |
Profit Margin | 12.53% | 12.31% | 13.57% | 6.76% | 9.81% | 7.93% | Upgrade |
Free Cash Flow Margin | - | 10.00% | 12.76% | 13.97% | 6.57% | 21.64% | Upgrade |
EBITDA | 7,998 | 7,907 | 8,337 | 4,864 | 6,231 | 6,101 | Upgrade |
EBITDA Margin | 14.87% | 14.97% | 17.01% | 10.03% | 14.68% | 16.13% | Upgrade |
D&A For EBITDA | 530.75 | 600 | 877 | 1,169 | 1,038 | 919 | Upgrade |
EBIT | 7,467 | 7,307 | 7,460 | 3,695 | 5,193 | 5,182 | Upgrade |
EBIT Margin | 13.89% | 13.84% | 15.22% | 7.62% | 12.24% | 13.70% | Upgrade |
Effective Tax Rate | 24.16% | 24.24% | 24.07% | 26.23% | 26.55% | 29.08% | Upgrade |
Revenue as Reported | 55,520 | 54,408 | 50,607 | 49,510 | 43,815 | 38,068 | Upgrade |
Advertising Expenses | - | 162 | 154 | 139 | 150 | 105 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.